Skip to content

Clinical trials

Phase 1/2 Hemophilia A trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 1/2 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20173
20183
20193
20202
20211
20222
20234
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Hoffmann-La Roche2
Spark Therapeutics, Inc.2
ASC Therapeutics1
ApcinteX Ltd1
Arditus Pte Ltd1
Baxalta now part of Shire1
Bayer1
Biocad1
Bioverativ, a Sanofi company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A23
Blood Coagulation Disorders6
Blood Coagulation Disorders, Inherited6
Coagulation Protein Disorders6
Genetic Diseases, Inborn6
Hematologic Diseases6
Hemorrhagic Disorders6
Hemophilia B3
Hemostatic Disorders3
Genetic Diseases, X-Linked2

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.